SCHEMBL4728677

SCHEMBL4728677

CS(=O)(=O)C(C(N)=O)S(C)(=O)=O

nearest known ligand 0.33

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
BLM P54132 2/20 0.33
PMP22 Q01453 2/20 0.33
CA1 P00915 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
LMNA P02545 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2180678 0.73
SCHEMBL1161632 0.73
SCHEMBL4721427 0.73
SCHEMBL27671399 0.73
SCHEMBL2931804 0.71
SCHEMBL27557197 0.71
SCHEMBL5902202 0.71
Hydrochloric Acid SCHEMBL3506396 0.71 CA14 (0.31) BLMPMP22CA1LMNAALOX15
SCHEMBL28140722 0.69 CA14 (0.30)
SCHEMBL7769458 0.69 PMP22 (0.30) PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3297434-A1 NON-AQUEOUS ORGANO LIQUID DELIVERY SYSTEMS CONTAINING DISPERSED POLY (ORGANIC ACIDS) THAT IMPROVE AVAILABILITY OF MACRO&MICRO-NUTRIENTS TO PLANTS Mcknight, Gary, David (US) 2018-03-28 EP disclosed
WO-2016183511-A1 NON-AQUEOUS ORGANO LIQUID DELIVERY SYSTEMS CONTAINING DISPERSED POLY (ORGANIC ACIDS) THAT IMPROVE AVAILABILITY OF MACRO & MICRO-NUTRIENTS TO PLANTS MCKNIGHT GARY DAVID (US) 2016-11-17 WO disclosed
EP-2970330-A1 TETRACYCLIC BROMODOMAIN INHIBITORS AbbVie Inc. (US) 2016-01-20 EP disclosed
WO-2014139324-A1 TETRACYCLIC BROMODOMAIN INHIBITORS ABBVIE INC. (US) 2014-09-18 WO disclosed
WO-2013063336-A1 REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS AND EFFICIENT METHODS OF PREPARING THEM VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2013-05-02 WO disclosed
EP-2580205-A1 CRYSTALLINE FORMS OF THALIDOMIDE AND PROCESSES FOR THEIR PREPARATION Generics [UK] Limited (GB) 2013-04-17 EP disclosed
WO-2011154739-A1 CRYSTALLINE FORMS OF THALIDOMIDE AND PROCESSES FOR THEIR PREPARATION GENERICS [UK] LIMITED (GB) 2011-12-15 WO disclosed
EP-1959966-A2 GANAXOLONE FORMULATIONS AND METHODS FOR THE MAKING AND USE THEREOF Marinus Pharmaceuticals, Inc. (US) 2008-08-27 EP disclosed
WO-2007062266-A2 GANAXOLONE FORMULATIONS AND METHODS FOR THE MAKING AND USE THEREOF MARINUS PHARMACEUTICALS (US) 2007-05-31 WO disclosed
EP-1325058-A2 EPISULFIDE BASED POLYMERIZABLE COMPOSITION CATALYZED BY AN (ALKOXYPHENYL)PHOSPHINE ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) 2003-07-09 EP disclosed
WO-2002024786-A2 EPISULFIDE BASED POLYMERIZABLE COMPOSITION CATALYZED BY AN (ALKOXYPHENYL)PHOSPHINE ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) 2002-03-28 WO disclosed
EP-0765879-B1 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests SANKYO CO (JP) 2001-02-14 EP disclosed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP disclosed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO disclosed
US-5861429-A MITICIDES AND ANTHELMINTICS SANKYO COMPANY, LIMITED (JP) 1999-01-19 US disclosed
EP-0765879-A1 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests SANKYO COMPANY LIMITED (JP) 1997-04-02 EP disclosed